Inventor

SIKORSKI JAMES A

US128 patents

⚠️ This page may combine multiple inventors who share the name “SIKORSKI JAMES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIKORSKI JAMES A

SEARLE & CO

Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity

Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity

Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity

Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity

Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity

Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity

Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity

Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors

(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity

Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications

Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors

Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity

Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors

PHARMACIA CORP

2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors

(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity

(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PFIZER

Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity

(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

ATHEROGENICS INC

Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality

1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders

MONSANTO CO

Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity

SEARLE LLC

Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications

SALUTRIA PHARMACEUTICALS LLC

Sulfonamide containing compounds for treatment of inflammatory disorders